PL342311A1 - Novel derivatives of carboxylic acids containing pyrimidinic rings substituted at position 5, method of obtaining them and application of such derivatives - Google Patents
Novel derivatives of carboxylic acids containing pyrimidinic rings substituted at position 5, method of obtaining them and application of such derivativesInfo
- Publication number
- PL342311A1 PL342311A1 PL99342311A PL34231199A PL342311A1 PL 342311 A1 PL342311 A1 PL 342311A1 PL 99342311 A PL99342311 A PL 99342311A PL 34231199 A PL34231199 A PL 34231199A PL 342311 A1 PL342311 A1 PL 342311A1
- Authority
- PL
- Poland
- Prior art keywords
- derivatives
- pyrimidinic
- obtaining
- application
- carboxylic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19806438A DE19806438A1 (en) | 1998-02-17 | 1998-02-17 | New pyrimidinyloxy-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiac insufficiency, restenosis, hypertension, kidney failure, asthma and prostate cancer |
PCT/EP1999/000776 WO1999042453A1 (en) | 1998-02-17 | 1999-02-05 | 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
PL342311A1 true PL342311A1 (en) | 2001-06-04 |
Family
ID=7857948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL99342311A PL342311A1 (en) | 1998-02-17 | 1999-02-05 | Novel derivatives of carboxylic acids containing pyrimidinic rings substituted at position 5, method of obtaining them and application of such derivatives |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1066268A1 (en) |
JP (1) | JP2002503726A (en) |
KR (1) | KR20010086247A (en) |
CN (1) | CN1291190A (en) |
AR (1) | AR014960A1 (en) |
AU (1) | AU3027199A (en) |
BG (1) | BG104577A (en) |
BR (1) | BR9907911A (en) |
CA (1) | CA2321182A1 (en) |
DE (1) | DE19806438A1 (en) |
HR (1) | HRP20000602A2 (en) |
HU (1) | HUP0100957A3 (en) |
IL (1) | IL137038A0 (en) |
NO (1) | NO20004075L (en) |
PL (1) | PL342311A1 (en) |
SK (1) | SK11512000A3 (en) |
TR (1) | TR200002376T2 (en) |
TW (1) | TW579376B (en) |
WO (1) | WO1999042453A1 (en) |
ZA (1) | ZA991214B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19924892A1 (en) * | 1999-06-01 | 2000-12-07 | Basf Ag | New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their production and use as endothelin receptor antagonists |
US8217155B2 (en) | 2007-07-31 | 2012-07-10 | Gilead Colorado, Inc. | Metabolites and derivatives of ambrisentan |
ES2549379T3 (en) | 2008-01-22 | 2015-10-27 | Dow Agrosciences Llc | 4-amino5-fluoropyrimidine derivatives as fungicides |
CA2731332A1 (en) * | 2008-08-01 | 2010-04-29 | Zoltan L. Benko | Use of 5-fluorocytosine as a fungicide |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4411225A1 (en) * | 1994-03-31 | 1995-10-05 | Basf Ag | Use of carboxylic acid derivatives as a drug |
DE19533023B4 (en) * | 1994-10-14 | 2007-05-16 | Basf Ag | New carboxylic acid derivatives, their preparation and use |
DE19614533A1 (en) * | 1996-04-12 | 1997-10-16 | Basf Ag | New alpha-hydroxy acid derivatives, their production and use |
DE19614534A1 (en) * | 1996-04-12 | 1997-10-16 | Basf Ag | New carboxylic acid derivatives, their production and use |
IL130251A0 (en) * | 1996-12-18 | 2000-06-01 | Basf Ag | Heterocyclic carboxylic acid derivatives the production and use thereof as endothelin receptor antagonists |
DE19726146A1 (en) * | 1997-06-19 | 1998-12-24 | Basf Ag | New ß-amino and ß-azidopcarboxylic acid derivatives, their preparation and use as endothelin receptor antagonists |
EP1027338A2 (en) * | 1997-10-31 | 2000-08-16 | Basf Aktiengesellschaft | New carboxylic acid derivatives, carrying amido side-chains; production and use as endothelin receptor antagonists |
-
1998
- 1998-02-17 DE DE19806438A patent/DE19806438A1/en not_active Withdrawn
-
1999
- 1999-02-05 TR TR2000/02376T patent/TR200002376T2/en unknown
- 1999-02-05 IL IL13703899A patent/IL137038A0/en unknown
- 1999-02-05 PL PL99342311A patent/PL342311A1/en unknown
- 1999-02-05 CA CA002321182A patent/CA2321182A1/en not_active Abandoned
- 1999-02-05 SK SK1151-2000A patent/SK11512000A3/en unknown
- 1999-02-05 EP EP99911657A patent/EP1066268A1/en not_active Withdrawn
- 1999-02-05 HU HU0100957A patent/HUP0100957A3/en unknown
- 1999-02-05 BR BR9907911-9A patent/BR9907911A/en not_active IP Right Cessation
- 1999-02-05 JP JP2000532405A patent/JP2002503726A/en active Pending
- 1999-02-05 WO PCT/EP1999/000776 patent/WO1999042453A1/en not_active Application Discontinuation
- 1999-02-05 KR KR1020007008925A patent/KR20010086247A/en not_active Application Discontinuation
- 1999-02-05 CN CN99803037A patent/CN1291190A/en active Pending
- 1999-02-05 AU AU30271/99A patent/AU3027199A/en not_active Abandoned
- 1999-02-10 TW TW088102031A patent/TW579376B/en active
- 1999-02-16 AR ARP990100634A patent/AR014960A1/en not_active Application Discontinuation
- 1999-02-16 ZA ZA9901214A patent/ZA991214B/en unknown
-
2000
- 2000-07-04 BG BG104577A patent/BG104577A/en unknown
- 2000-08-15 NO NO20004075A patent/NO20004075L/en not_active Application Discontinuation
- 2000-09-13 HR HR20000602A patent/HRP20000602A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20010086247A (en) | 2001-09-10 |
NO20004075D0 (en) | 2000-08-15 |
EP1066268A1 (en) | 2001-01-10 |
CA2321182A1 (en) | 1999-08-26 |
AR014960A1 (en) | 2001-04-11 |
TR200002376T2 (en) | 2000-12-21 |
WO1999042453A1 (en) | 1999-08-26 |
JP2002503726A (en) | 2002-02-05 |
HRP20000602A2 (en) | 2001-06-30 |
BG104577A (en) | 2001-03-30 |
BR9907911A (en) | 2000-10-24 |
HUP0100957A2 (en) | 2002-02-28 |
HUP0100957A3 (en) | 2002-03-28 |
SK11512000A3 (en) | 2001-04-09 |
AU3027199A (en) | 1999-09-06 |
DE19806438A1 (en) | 1999-08-19 |
TW579376B (en) | 2004-03-11 |
IL137038A0 (en) | 2001-06-14 |
ZA991214B (en) | 2000-08-16 |
NO20004075L (en) | 2000-08-15 |
CN1291190A (en) | 2001-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9710038B (en) | Method for the production of levulinic acid and its derivatives | |
PL325155A1 (en) | Method of obtaining l-amino acids | |
PL332720A1 (en) | Novel derivatives of piperydinketone carboxylic acids, their production and application | |
PL330363A1 (en) | Novel derivatives of substituted 2,4-thiazolydinodione, method of obtaining them and pharmaceutic compositions containing such derivatives | |
PL340034A1 (en) | Derivatives of tetrahydropyridopyrimidinone substituted at position 3, method of obtaining them and method of applying them | |
PL319270A1 (en) | Novel derivative of 2,3-dibenzodiazepin, method of obtaining them and pharmaceutic composition | |
PL329240A1 (en) | Novel derivatives of carboxylic acid, their production and application | |
PL342311A1 (en) | Novel derivatives of carboxylic acids containing pyrimidinic rings substituted at position 5, method of obtaining them and application of such derivatives | |
PL339759A1 (en) | Method of obtaining substituted 4-phenyl-4-cyanohexanic acids | |
PL324588A1 (en) | Novel compounds-substituted piperydinodiones-2,6, method of obtaining them and drug containing such compounds | |
PL322279A1 (en) | Method of obtaining 1,2-benzoylthiazolin-3-ones | |
PL323388A1 (en) | Method of obtaining derivatives of carboxylic acids | |
PL340033A1 (en) | Derivatives of 1,2-benzoisothiazole substituted at position 2, method of obtaining them and method of applying them | |
PL335031A1 (en) | Compound and method of obtaining substituted 4-phenyl-4-cyanocyclohexanic acids | |
PL327141A1 (en) | Method of obtaining 9,11 beta-epoxysteroides | |
PL325398A1 (en) | Novel derivatives of carboxylic acids, their production and application | |
PL330281A1 (en) | Method of obtaining derivatives of phenoxypropinic acid | |
PL334621A1 (en) | Method of obtaining derivatives of quinolone and naphtyridone carboxylic acids | |
PL314587A1 (en) | Derivatives of 2,3,5,6-terafluorobenzoic acid and method of obtaining them | |
PL319070A1 (en) | Derivatives of 1,25-dihydroxy-16,22,23-trisdehyrochoecalcifero, method of obtaining them and compositions containing such derivatives | |
PL326699A1 (en) | Method of obtaining derivatives of 3-phenyl-1-methylenedioxyphenyl-indane 2-carboxylic acids | |
PL302364A1 (en) | Method of carrying on hydrocarboxylation of lactones | |
PL315675A1 (en) | Derivatives of 12, 13-epoxytholosine and method of obtaining them | |
PL336664A1 (en) | Method of obtaining 1,1,1,3,3- pentachlorobutane | |
SI0726270T1 (en) | Derivatives of 1,6-naphthyridone carboxylic acids |